Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruoning Wang

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Nature Metabolism|August 7, 2023
Asparagine restriction enhances CD8<sup>+</sup> T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress responseJ N Rashida Gnanaprakasam, Bhavana Kushwaha, Lingling Liu, et al.
Science Immunology|April 29, 2022
Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammationXuyong Chen, Benjamin Sunkel, Meng Wang, et al.
Cancer Research|November 12, 2024
Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or SomatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Conditional c-MYC activation in catecholaminergic cells drives distinct neuroendocrine tumors: neuroblastoma vs somatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitorCarolyn Jablonowski, Waise Quarni, Shivendra Singh, et al.
Elife|March 15, 2024
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitorCarolyn M Jablonowski, Waise Quarni, Shivendra Singh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 29, 2025
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cellsAnna Maria Giudice, Sydney L Roth, Stephanie Matlaga, et al.
Science Advances|September 16, 2022
Targeting OXPHOS de novo purine synthesis as the nexus of <i>FLT3</i> inhibitor-mediated synergistic antileukemic actionsPu Zhang, Lindsey T Brinton, Mehdi Gharghabi, et al.
Science Advances|November 17, 2021
Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma modelsShivendra Singh, Waise Quarni, Maria Goralski, et al.
Nature Metabolism|July 23, 2020
Inosine is an alternative carbon source for CD8<sup>+</sup>-T-cell function under glucose restrictionTingting Wang, J N Rashida Gnanaprakasam, Xuyong Chen, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Nature Metabolism|August 7, 2023
Asparagine restriction enhances CD8<sup>+</sup> T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress responseJ N Rashida Gnanaprakasam, Bhavana Kushwaha, Lingling Liu, et al.
Science Immunology|April 29, 2022
Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammationXuyong Chen, Benjamin Sunkel, Meng Wang, et al.
Cancer Research|November 12, 2024
Conditional Activation of c-MYC in Distinct Catecholaminergic Cells Drives Development of Neuroblastoma or SomatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Conditional c-MYC activation in catecholaminergic cells drives distinct neuroendocrine tumors: neuroblastoma vs somatostatinomaTingting Wang, Lingling Liu, Jie Fang, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitorCarolyn Jablonowski, Waise Quarni, Shivendra Singh, et al.
Elife|March 15, 2024
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitorCarolyn M Jablonowski, Waise Quarni, Shivendra Singh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 29, 2025
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cellsAnna Maria Giudice, Sydney L Roth, Stephanie Matlaga, et al.
Science Advances|September 16, 2022
Targeting OXPHOS de novo purine synthesis as the nexus of <i>FLT3</i> inhibitor-mediated synergistic antileukemic actionsPu Zhang, Lindsey T Brinton, Mehdi Gharghabi, et al.
Science Advances|November 17, 2021
Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma modelsShivendra Singh, Waise Quarni, Maria Goralski, et al.
Nature Metabolism|July 23, 2020
Inosine is an alternative carbon source for CD8<sup>+</sup>-T-cell function under glucose restrictionTingting Wang, J N Rashida Gnanaprakasam, Xuyong Chen, et al.
Pageof 15